BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2009557)

  • 1. Identification of ischemic and hibernating myocardium: feasibility of post-exercise F-18 deoxyglucose positron emission tomography.
    Marwick TH; MacIntyre WJ; Salcedo EE; Go RT; Saha G; Beachler A
    Cathet Cardiovasc Diagn; 1991 Feb; 22(2):100-6. PubMed ID: 2009557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization.
    Marwick TH; Nemec JJ; Lafont A; Salcedo EE; MacIntyre WJ
    Am J Cardiol; 1992 Apr; 69(9):854-9. PubMed ID: 1550012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
    Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
    Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
    Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism.
    Marwick TH; MacIntyre WJ; Lafont A; Nemec JJ; Salcedo EE
    Circulation; 1992 Apr; 85(4):1347-53. PubMed ID: 1555279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.
    Go RT; MacIntyre WJ; Cook SA; Neumann DR; Brunken RC; Saha GB; Underwood DA; Marwick TH; Chen EQ; King JL; Khandekar S
    J Nucl Cardiol; 1996; 3(2):96-104. PubMed ID: 8799234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
    Go RT; MacIntyre WJ; Saha GB; Cook SA; Neumann DR; Chen EQ; Underwood DA; Kaczur T
    Radiology; 1995 Jan; 194(1):151-5. PubMed ID: 7997543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
    Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
    Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of reversible ischemia after coronary artery bypass grafting by positron emission tomography.
    Tamaki N; Yonekura Y; Yamashita K; Ohtani H; Hirata K; Ban T; Konishi J
    J Cardiol; 1991; 21(2):193-201. PubMed ID: 1841906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative planar imaging of glucose metabolic activity in myocardial segments with exercise thallium-201 perfusion defects in patients with myocardial infarction: comparison with late (24-hour) redistribution thallium imaging for detection of reversible ischemia.
    Williams KA; Taillon LA; Stark VJ
    Am Heart J; 1992 Aug; 124(2):294-304. PubMed ID: 1636573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography.
    Tamaki N; Kawamoto M; Tadamura E; Magata Y; Yonekura Y; Nohara R; Sasayama S; Nishimura K; Ban T; Konishi J
    Circulation; 1995 Mar; 91(6):1697-705. PubMed ID: 7882476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.
    Fallavollita JA; Perry BJ; Canty JM
    Circulation; 1997 Apr; 95(7):1900-9. PubMed ID: 9107179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.